Statement of deviation(s) or variation(s) under Reg. 32

Date: 02.11.2026 Letter No. FFL/SEC/2026-27/SE-95 To, To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai - 400 001 Mumbai – 400 051 Scrip Code: FUSION Scrip Code: 543652, 977381, 977412 Sub.: Statement of deviation or variation in the use of proceeds of Equity Shares issued through Rights Issue for the Quarter ended September 30, 2026 Dear Sir/ Madam, Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that there is no deviation or variation in the use of proceeds of the Rights Issue of equity shares during the quarter ended September 30, 2026 from the objects stated in the Letter of Offer dated March 29, 2025. Accordingly, please find attached the statement indicating no deviation or variation in the utilisation of funds raised through “Rights Issue” as Annexure A for the quarter ended September 30, 2026, duly reviewed by the Audit Committee of the Company in its meeting held today, i.e., Monday, November 02, 2026. The copy of this letter is also available on the website of the Company viz. www.fusionfin.com. You are requested to kindly take the above on record. Thanking You, Yours Truly, For Fusion Finance Limited Vikrant Sadana Company Secretary & Compliance Officer Place: Gurugram Encl.: a/a Annexure-A Statement of Deviation / Variation in utilization of funds raised Name of listed entity Fusion Finance Limited Mode of Fund Raising Rights Issue Date of Raising Funds May 02, 2025 (being the date of Allotment of Partly Paid Up Equity shares) Amount Raised Total Rights Issue size: INR 799.86 Crores Amount raised pursuant to issuance of Partly Paid-up Equity Shares: INR 798.79 Crores (refer note below) Report filed for Quarter ended September 30, 2026 Monitoring Agency Applicable Monitoring Agency Name, if applicable CRISIL Ratings Limited Is there a Deviation / Variation in use of No funds raised If yes, whether the same is pursuant to Not Applicable change in terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval Not Applicable Explanation for the Deviation / Variation Not Applicable Comments of the Audit Committee after No Comments review Comments of the auditors, if any No Comments Objects for which funds have been raised and where there has been a deviation, in the following table Amount of Modified Modified Original Funds Deviation/Variation for Remarks if Original Object Object, if allocation, Allocation Utilised the quarter according any any if any to applicable object The net proceeds from the rights issue of equity shares to Not INR 783.34 #INR 782.31 INR No deviation/ Variation Note 1 be utilized towards augmenting the capital base of the Applicable Crores* 782.31 in utilization of fund Company to meet future capital requirements. crore raised through Rights Issue expenses Not INR 16.52 INR 16.48 INR 16.48 Issue Note 2 Applicable Crores crores crore * The total Rights Issue size was ₹799.86 crore, which was allotted on May 2, 2025 at an issue price of ₹131 per equity share (face value of ₹10 each and premium of ₹121 each). An amount of ₹65.50 per equity share (face value of ₹5 each and premium of ₹60.50 each) was received on application, aggregating to ₹399.93 crore. The balance amount of ₹65.50 per equity share was called on November 13, 2025 and was payable by December 11, 2025, against which the Company received ₹395.30 crore out of the total call money of ₹399.93 crore. Further, the Company received an additional Rs 2.06 crore during the quarter ended March 31, 2026, Rs 0.52 crore during June 30, 2026, and Rs 0.98 crore during the quarter ended September 30, 2026, towards the outstanding call money. Accordingly, the cumulative amount received under the Rights Issue stood at Rs 798.79 crore as at September 30, 2026. # Transactions are made towards disbursement of loans meant for the expansion of the company & that is made from the company’s designated Escrow Account. Note 1: Pursuant to the final call notice, the Rights Issue Committee approved the forfeiture of 1,63,028 partly paid-up equity shares on account of non-payment of call money. Against these shares, Rs. 1.07 crore had been received towards application money, while Rs. 1.07 crore remained outstanding as calls in arrears. Accordingly, the balance has been revised to this extent. Note 2: The Company had estimated issue expenses of Rs. 16.52 crore. Against this, actual expenses incurred amounted to Rs. 16.48 crore. The unutilized balance of Rs. 0.04 crore has been reallocated to the stated object of the Issue, namely augmentation of the Company's capital base. Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc For Fusion Finance Limited Vikrant Sadana Company Secretary & Compliance Officer